#Sample Identifier	Patient Identifier	Retrospective or Prospective	Biopsy Obtained at MSK or OSH	IMPACT pre/post	Cancer Type	Cancer Type Detailed	Oncotree Code	Sample Type	Stage At Diagnosis	Liver Metastasis	Lung Metastasis	Peritoneum Metastasis	Metastatic Site Other	H-PYLORI	Site of Tissue Biopsy	Gene Panel	Mutation Rate	MSI Sensor Score	FGA	Molecular Subtype	HER2 Total Time Period on First Line (Months)	HER2 Response	HER2 Vital Status	HER2 Treatment Status	EGC Overall Survival from start of IO to date of death/follow up/POD	IO Regimen Monotherapy Vs Combination	IO Response	IO EBV Tested	IO PDL1 Tested	IO Mutation Group	IHC-HER2	HER2 FISH	HER2 IHC or FISH	HER2 IMPACT	HER2 IMPACT LR	TMB (nonsynonymous)
#A unique sample identifier.	Identifier to uniquely specify a patient.	Is the sample retrospective or prospective	Biopsy Obtained at MSK or OSH	IMPACT pre/post	Cancer Type	Cancer Type Detailed	Oncotree Code	The type of sample (i.e., normal, primary, met, recurrence).	Stage At Diagnosis	Liver Metastasis	Lung Metastasis	Peritoneum Metastasis	Metastatic Site Other	H-PYLORI.	Site of Tissue Biopsy	Gene panel.	Mutation Rate	MSI Sensor Score	FGA	Molecular subtype.	HER2 Total Time Period on First Line (Months)	HER2 Response	HER2 Vital Status	HER2 Treatment Status	EGC Overall Survival from start of IO to date of death/follow up/POD	IO Regimen Monotherapy Vs Combination	IO Response	IO EBV Tested	IO PDL1 Tested	IO Mutation Group	IHC-HER2	HER2 FISH	HER2 IHC or FISH	HER2 IMPACT	HER2 IMPACT LR	TMB (nonsynonymous)
#STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	NUMBER	NUMBER	STRING	NUMBER	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	STRING	STRING	NUMBER	STRING
#1	1	1	1	1	1	1	1	9	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
SAMPLE_ID	PATIENT_ID	RETROSPECTIVE_OR_PROSPECTIVE	BIOPSY_OBTAINED	IMPACT_PRE_POST	CANCER_TYPE	CANCER_TYPE_DETAILED	ONCOTREE_CODE	SAMPLE_TYPE	STAGE_AT_DIAGNOSIS	MET_LIVER	MET_LUNG	MET_PERITONEUM	METASTATIC_SITE_OTHER	H_PYLORI	SITE_OF_TISSUE_BIOPSY	GENE_PANEL	MUTATION_RATE	MSI_SENSOR_SCORE	FGA	MOLECULAR_SUBTYPE	HER2_TTP_ON_1ST_LINE_MONTHS	HER2_RESPONSE	HER2_VITAL_STATUS	HER2_TX_STATUS	IO_EGC_SURVIVAL_OS_MONTHS_START_OF_IO_TO_DATE_OF_DEATH_LAST_FOLLOW_UP	IO_REGIMEN_MONOTHERAPY_VS_COMBINATION	IO_RESPONSE	IO_EBV_TESTED	IO_PDL1_TESTED	IO_MUT_GROUPS	IHC_HER2	HER2_FISH	HER2_IHC_OR_FISH	HER2_IMPACT	HER2_IMPACT_LR	TMB_NONSYNONYMOUS
P-0000062-T01-IM3	P-0000062	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	NO	YES	NONE	NEGATIVE	GEJ	IMPACT341	6.12244898	2.22	0.41	CIN	NA	NA	NA	NA	DOD	Monotherapy	POD	NEGATIVE	not tested	0	IHC 2+	3.4	POS	AMP	1.6343	6.72929396248
P-0000076-T01-IM3	P-0000076	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T2N3a	NO	NO	NO	LN	POSITIVE	Body	IMPACT341	3.06122449	0.5	0	CIN	5.23	CR	NED	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.5492	3.36464698124
P-0000086-T01-IM3	P-0000086	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	T2N0	YES	NO	NO	LN	NEGATIVE	Liver	IMPACT341	3.06122449	1.3	0.065	CIN	7.63	SD	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	2.5047	3.36464698124
P-0000103-T01-IM3	P-0000103	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	T3N1	NO	NO	NO	LN	NEGATIVE	Lymph Nodes	IMPACT341	6.12244898	2.25	0.41	CIN	NA	NA	NA	NA	DOD	Combination	POD	NEGATIVE	not evaluable	0	N/A	NA	NEG	DIPLOID	-0.0064	6.72929396248
P-0000112-T01-IM3	P-0000112	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N0	NO	NO	NO	adrenal	NEGATIVE	GEJ	IMPACT341	8.163265306	2.76	0.36	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.2218	8.97239194997
P-0000115-T01-IM3	P-0000115	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	NO	NO	NONE	NEGATIVE	GEJ	IMPACT341	6.12244898	0.48	0.03	CIN	25.67	CR	AWD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	2.1365741	6.72929396248
P-0000117-T01-IM3	P-0000117	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	NO	NONE	UNKNOWN	Distal	IMPACT341	5.102040816	0.53	0.35	CIN	14.57	PR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 2+	2	POS	AMP	0.8577704	5.60774496873
P-0000121-T01-IM3	P-0000121	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	LN	NEGATIVE	Body	IMPACT341	3.06122449	0.28	0.07	CIN	NA	NA	NA	NA	LTF	Monotherapy	POD	INSUFFICIENT TISSUE	not evaluable	0	N/A	NA	NEG	AMP	2.1711148	3.36464698124
P-0000144-T01-IM3	P-0000144	PROSPECTIVE	OSH	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	YES	YES	LN	UNKNOWN	GEJ	IMPACT341	5.102040816	0.3	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.0033	5.60774496873
P-0000178-T01-IM3	P-0000178	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N0	NO	YES	NO	LN	UNKNOWN	GEJ	IMPACT341	6.12244898	0.81	0.1	CIN	17.43	PR	LTF	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	4.0635	6.72929396248
P-0000180-T01-IM3	P-0000180	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	YES	NONE	NEGATIVE	Peritoneum	IMPACT341	1.020408163	0	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0283	1.12154899375
P-0000180-T02-IM3	P-0000180	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	NONE	NEGATIVE	Body	IMPACT341	4.081632653	0	0.03	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	-0.0278	4.48619597498
P-0000186-T01-IM3	P-0000186	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN	UNKNOWN	GEJ	IMPACT341	6.12244898	0.35	0.07	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0849	6.72929396248
P-0000221-T01-IM3	P-0000221	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN, adrenal	UNKNOWN	GEJ	IMPACT341	1.020408163	0.83	0.1	CIN	12.13	SD	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	AMP	1.0801	1.12154899375
P-0000225-T01-IM3	P-0000225	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	NO	NO	LN	UNKNOWN	GEJ	IMPACT341	5.102040816	1.1	0.03	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0058	7.85084295622
P-0000249-T02-IM3	P-0000249	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	NO	NONE	POSITIVE	Distal	IMPACT341	1.020408163	0.39	0.1	CIN	NA	NA	NA	NA	DOD	Monotherapy	POD	NOT TESTED	negative	0	N/A	NA	NEG	DIPLOID	0.0207	1.12154899375
P-0000282-T01-IM3	P-0000282	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	LN	NEGATIVE	Distal	IMPACT341	1.020408163	0	0	CIN	23.3	CR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	2.6923	1.12154899375
P-0000282-T02-IM5	P-0000282	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	YES	LN	NEGATIVE	Fallopian Tube/Ovary	IMPACT410	2.830188679	1.16	0.37	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	AMP	1.9729	2.98069700619
P-0000300-T01-IM3	P-0000300	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	YES	NONE	NEGATIVE	Colon	IMPACT341	2.040816327	0	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0098	2.24309798749
P-0000342-T01-IM3	P-0000342	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	NO	NO	NO	LN, bone	NEGATIVE	GEJ	IMPACT341	5.102040816	0.63	0.15	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	-0.0924	5.60774496873
P-0000369-T01-IM3	P-0000369	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	NONE	NEGATIVE	Body	IMPACT341	3.06122449	0.09	0	CIN	NA	NA	NA	NA	DOD	Combination	POD	NEGATIVE	not tested	0	N/A	NA	NEG	DIPLOID	-0.0405	3.36464698124
P-0000383-T01-IM3	P-0000383	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	bone	NEGATIVE	GEJ	IMPACT341	3.06122449	1.14	0.22	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.1684	3.36464698124
P-0000408-T01-IM3	P-0000408	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	YES	NO	NO	brain	NEGATIVE	Occipital	IMPACT341	7.142857143	2.51	0.48	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	AMP	1.0232	7.85084295622
P-0000436-T01-IM3	P-0000436	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	YES	YES	NO	LN	UNKNOWN	Lymph Nodes	IMPACT341	4.081632653	0.26	0.33	CIN	24.27	SD	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	4.8681	4.48619597498
P-0000444-T01-IM3	P-0000444	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	T3N1	YES	NO	NO	NONE	UNKNOWN	Liver	IMPACT341	3.06122449	0.75	0.21	CIN	25.43	CR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	4.5226	3.36464698124
P-0000444-T02-IM5	P-0000444	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N1	YES	NO	NO	NONE	UNKNOWN	GEJ	IMPACT410	10.37735849	0.16	0.11	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1	NEG	DIPLOID	0.0955	10.929222356
P-0000446-T01-IM3	P-0000446	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	YES	NO	NO	bone	NEGATIVE	Liver	IMPACT341	5.102040816	0.35	0.13	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.1249	5.60774496873
P-0000485-T01-IM3	P-0000485	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T2bN0	NO	NO	YES	LN	UNKNOWN	Upper	IMPACT341	13.26530612	0.26	0.05	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0703	14.5801369187
P-0000488-T01-IM3	P-0000488	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	YES	LN	NEGATIVE	Cardia	IMPACT341	1.020408163	0.07	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	-0.0029	1.12154899375
P-0000523-T01-IM3	P-0000523	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	T4aN2	NO	NO	NO	adrenal	NEGATIVE	Adrenal	IMPACT341	5.102040816	0.46	0.09	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0038	5.60774496873
P-0000538-T01-IM3	P-0000538	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	NO	NO	LN	NEGATIVE	GEJ	IMPACT341	3.06122449	2.01	0.22	CIN	37.3	CR	NED	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.9188	3.36464698124
P-0000553-T01-IM3	P-0000553	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Metastasis	IV	YES	NO	NO	LN	POSITIVE	Lymph Nodes	IMPACT341	6.12244898	1.82	0.33	CIN	NA	NA	NA	NA	DOD	Combination	POD	INSUFFICIENT TISSUE	not tested	0	IHC 0+	NA	NEG	DIPLOID	0.1355	6.72929396248
P-0000553-T02-IM5	P-0000553	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	NO	NO	LN	POSITIVE	Cardia	IMPACT410	6.603773585	NA	0.06	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0587	6.95495968111
P-0000570-T01-IM3	P-0000570	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	YES	NO	NO	NONE	POSITIVE	Liver	IMPACT341	3.06122449	0.6	0.15	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	3.9	POS	AMP	1.2571	3.36464698124
P-0000574-T01-IM3	P-0000574	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	LN	NEGATIVE	Distal	IMPACT341	2.040816327	NA	0.06	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.0157	2.24309798749
P-0000605-T01-IM3	P-0000605	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	YES	Ovary	NEGATIVE	Body	IMPACT341	17.34693878	NA	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0095	19.0663328937
P-0000716-T01-IM3	P-0000716	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	YES	NO	LN	UNKNOWN	GEJ	IMPACT341	6.12244898	4.95	0.41	CIN	7.07	PR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	AMP	2.4781	6.72929396248
P-0000722-T01-IM3	P-0000722	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	NO	NO	NONE	NEGATIVE	GEJ	IMPACT341	1.020408163	0.16	0.09	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.5217	1.12154899375
P-0000730-T01-IM3	P-0000730	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	NO	NO	NONE	UNKNOWN	GEJ	IMPACT341	3.06122449	0	0.08	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0945	3.36464698124
P-0000751-T01-IM3	P-0000751	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	T2N0	YES	NO	NO	NONE	UNKNOWN	Liver	IMPACT341	6.12244898	0.25	0.06	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.1145	6.72929396248
P-0000776-T01-IM3	P-0000776	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN	UNKNOWN	GEJ	IMPACT341	2.040816327	2.64	0.28	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.0394	2.24309798749
P-0000787-T01-IM3	P-0000787	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	YES	NO	LN, ovary	UNKNOWN	Distal	IMPACT341	1.020408163	0.63	0.01	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.0578	1.12154899375
P-0000793-T02-IM5	P-0000793	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	YES	NO	YES	LN	UNKNOWN	Liver	IMPACT410	3.773584906	0.99	0.23	CIN	NA	NA	NA	NA	DOD	Monotherapy	POD	NEGATIVE	not tested	0	N/A	NA	NEG	DIPLOID	0.737	3.97426267492
P-0000797-T01-IM3	P-0000797	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	NONE	POSITIVE	Distal	IMPACT341	1.020408163	0.5	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.1015	1.12154899375
P-0000797-T02-IM3	P-0000797	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	YES	NONE	POSITIVE	Pelvic peritoneal	IMPACT341	1.020408163	0.16	0.02	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0557	1.12154899375
P-0000814-T01-IM3	P-0000814	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	Ovary	NEGATIVE	Distal	IMPACT341	2.040816327	0.09	0.07	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0051	2.24309798749
P-0000870-T01-IM3	P-0000870	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	NO	NO	LN, bone	NEGATIVE	GEJ	IMPACT341	3.06122449	0	0.03	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0273	3.36464698124
P-0000899-T01-IM3	P-0000899	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	YES	NO	LN	NEGATIVE	GEJ	IMPACT341	5.102040816	1.69	0.2	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.1339	5.60774496873
P-0000938-T01-IM3	P-0000938	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	YES	NO	LN	UNKNOWN	GEJ	IMPACT341	3.06122449	0.09	0.1	CIN	NA	NA	NA	NA	DOD	Combination	POD	NOT TESTED	not tested	0	IHC 1+	NA	NEG	DIPLOID	0.0514	3.36464698124
P-0000977-T01-IM3	P-0000977	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	NO	NO	LN	NEGATIVE	GEJ	IMPACT341	6.12244898	1.35	0.2	CIN	NA	NA	NA	NA	DOD	Combination	POD	INSUFFICIENT TISSUE	not evaluable	0	IHC 1+	NA	NEG	DIPLOID	0.0974	6.72929396248
P-0000991-T01-IM3	P-0000991	PROSPECTIVE	OSH	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	T3N2	YES	YES	NO	LN	UNKNOWN	Lung	IMPACT341	9.183673469	1.54	0.44	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.9227	10.0939409437
P-0001023-T01-IM3	P-0001023	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	T3N1	NO	YES	NO	LN	UNKNOWN	Lung	IMPACT341	6.12244898	0	0.04	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.0446	6.72929396248
P-0001047-T01-IM3	P-0001047	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	NO	NO	NO	LN	NEGATIVE	GEJ	IMPACT341	6.12244898	0.18	0.02	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	3.2	POS	DIPLOID	0.0376	6.72929396248
P-0001047-T02-IM5	P-0001047	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Metastasis	IV	NO	NO	NO	LN	NEGATIVE	Omental nodule	IMPACT410	14.1509434	2.15	0.46	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	1.5	POS	DIPLOID	0.2676	14.9034850309
P-0001077-T01-IM3	P-0001077	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T2bN1	YES	NO	NO	bone	NEGATIVE	GEJ	IMPACT341	6.12244898	0.73	0.32	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.1484	6.72929396248
P-0001136-T01-IM3	P-0001136	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	YES	NO	NO	LN, adrenal, bone	UNKNOWN	Liver	IMPACT341	6.12244898	0.16	0.05	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.2811	6.72929396248
P-0001137-T01-IM3	P-0001137	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	NONE	NEGATIVE	GEJ	IMPACT341	3.06122449	1.55	0.18	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.1089	3.36464698124
P-0001158-T01-IM3	P-0001158	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	YES	LN	NEGATIVE	Body	IMPACT341	5.102040816	0.44	0.05	CIN	5.6	SD	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	2.4911	5.60774496873
P-0001172-T02-IM3	P-0001172	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	NONE	NEGATIVE	Body	IMPACT341	2.040816327	0.24	0.05	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.0601	2.24309798749
P-0001180-T01-IM3	P-0001180	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	YES	NO	LN, ovary, breast, skin [lung=pleura]	UNKNOWN	Breast	IMPACT341	2.040816327	0.08	0.01	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.0166	2.24309798749
P-0001194-T01-IM3	P-0001194	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN	NEGATIVE	GEJ	IMPACT341	9.183673469	0.75	0.17	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	-0.0379	10.0939409437
P-0001197-T01-IM3	P-0001197	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	YES	NO	YES	NONE	UNKNOWN	Peritoneal nodule	IMPACT341	3.06122449	0.71	0.17	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0149	3.36464698124
P-0001222-T01-IM3	P-0001222	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	NO	NO	LN, bone	NEGATIVE	GEJ	IMPACT341	9.183673469	0.33	0.05	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.031	10.0939409437
P-0001231-T01-IM3	P-0001231	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	YES	NO	NO	LN	NEGATIVE	Liver	IMPACT341	4.081632653	1.62	0.37	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	AMP	0.9811	4.48619597498
P-0001260-T01-IM3	P-0001260	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	YES	LN, colon	NEGATIVE	Omentum	IMPACT341	3.06122449	0	0	GS	NA	NA	NA	NA	DOD	Monotherapy	POD	NOT TESTED	negative	0	IHC 0+	NA	NEG	DIPLOID	-0.0581	3.36464698124
P-0001275-T01-IM3	P-0001275	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	colon, brain	UNKNOWN	not sure	IMPACT341	1.020408163	0.69	0.2	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.2	NEG	DIPLOID	0.3988593	1.12154899375
P-0001298-T01-IM3	P-0001298	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	NONE	NEGATIVE	GEJ	IMPACT341	6.12244898	0.27	0.05	GS	NA	NA	NA	NA	DOD	Monotherapy	POD	NOT TESTED	not tested	0	N/A	NA	NEG	DIPLOID	0.0946	6.72929396248
P-0001301-T01-IM3	P-0001301	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	T2bN0	NO	NO	YES	NONE	POSITIVE	Peritoneal fluid	IMPACT341	3.06122449	0.93	0.44	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0591	3.36464698124
P-0001323-T01-IM3	P-0001323	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	NONE	UNKNOWN	GEJ	IMPACT341	4.081632653	0.77	0.25	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.3	NEG	DIPLOID	0.0865	4.48619597498
P-0001393-T01-IM3	P-0001393	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	YES	NO	YES	NONE	NEGATIVE	Liver	IMPACT341	7.142857143	2.5	0.37	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	5.3	POS	AMP	1.8917	7.85084295622
P-0001495-T01-IM3	P-0001495	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN	NEGATIVE	GEJ	IMPACT341	6.12244898	0.97	0.35	CIN	14	PR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	AMP	2.7649	6.72929396248
P-0001495-T02-IM5	P-0001495	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN	NEGATIVE	Distal	IMPACT410	6.603773585	0.62	0.23	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	2.5678	6.95495968111
P-0001495-T03-IM5	P-0001495	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN	NEGATIVE	GEJ	IMPACT410	12.26415094	1.28	0.27	CIN	NA	NA	NA	NA	DOD	Monotherapy	POD	NEGATIVE	not tested	1	IHC 3+	NA	POS	AMP	2.7631	12.9163536935
P-0001510-T01-IM3	P-0001510	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T2N1	YES	YES	NO	LN, bone	NEGATIVE	GEJ	IMPACT341	5.102040816	0.48	0.37	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.141	5.60774496873
P-0001543-T01-IM3	P-0001543	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N1	YES	NO	NO	NONE	NEGATIVE	GEJ	IMPACT341	3.06122449	0.95	0.21	CIN	NA	NA	NA	NA	DOD	Combination	POD	NEGATIVE	negative	0	N/A	NA	NEG	DIPLOID	0.1003	3.36464698124
P-0001551-T01-IM3	P-0001551	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	YES	Ovary	POSITIVE	Lesser curvature	IMPACT341	1.020408163	0	0.01	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	-0.0516	1.12154899375
P-0001551-T02-IM5	P-0001551	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	YES	Ovary	POSITIVE	Lung	IMPACT410	0.943396226	0.08	0	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	-0.0218	0.993565668729
P-0001583-T01-IM3	P-0001583	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	YES	NO	NO	LN	UNKNOWN	Liver	IMPACT341	11.2244898	0.28	0.19	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.053	12.3370389312
P-0001586-T02-IM5	P-0001586	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Metastasis	IV	NO	NO	NO	brain	NEGATIVE	Brain	IMPACT410	4.716981132	1.41	0.39	CIN	24.73	CR	AWD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	AMP	5.1654	4.96782834365
P-0001600-T01-IM3	P-0001600	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	NO	ovary, uterus	UNKNOWN	Uterus, cervix, tubes and ovaries	IMPACT341	4.081632653	0	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0456	4.48619597498
P-0001667-T01-IM3	P-0001667	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Metastasis	IV	YES	NO	NO	NONE	NEGATIVE	Liver	IMPACT341	2.040816327	1.61	0.21	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0751	2.24309798749
P-0001699-T01-IM3	P-0001699	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	YES	NO	NONE	NEGATIVE	Cardia	IMPACT341	1.020408163	2.9	0.55	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.1951	1.12154899375
P-0001699-T02-IM5	P-0001699	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	YES	NO	NONE	NEGATIVE	Cardia	IMPACT410	2.830188679	0.07	0.17	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	-0.0433	2.98069700619
P-0001733-T01-IM3	P-0001733	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN, adrenal	NEGATIVE	GEJ	IMPACT341	4.081632653	2.14	0.34	CIN	NA	NA	NA	NA	AWD	Combination	PR	NEGATIVE	positive	0	IHC 2+	1	NEG	DIPLOID	0.3577	4.48619597498
P-0001764-T01-IM3	P-0001764	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	YES	NONE	NEGATIVE	Cardia	IMPACT341	5.102040816	1.61	0.51	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	NA	NEG	DIPLOID	0.1552	5.60774496873
P-0001850-T01-IM3	P-0001850	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	LN	POSITIVE	Body	IMPACT341	1.020408163	0	0.03	CIN	NA	NA	NA	NA	AWD	Monotherapy	SD	NOT TESTED	positive	0	IHC 0+	NA	NEG	DIPLOID	-0.0918	1.12154899375
P-0001855-T01-IM3	P-0001855	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	YES	YES	NO	retroperintoneum	UNKNOWN	Liver	IMPACT341	4.081632653	0	0.1	CIN	30.03	PR	AWD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.5751	4.48619597498
P-0001855-T03-IM6	P-0001855	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	YES	NO	retroperintoneum	UNKNOWN	Esophagus	IMPACT468	5.737704918	0	0.026	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	1.8071	6.179705846
P-0001996-T01-IM3	P-0001996	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	YES	NO	NO	LN, brain, adrenal, bone	NEGATIVE	Brain	IMPACT341	6.12244898	4.91	0.68	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.1	NEG	DIPLOID	0.6844	6.72929396248
P-0002027-T01-IM3	P-0002027	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	NO	bone	UNKNOWN	Femoral head and curettings	IMPACT341	5.102040816	0	0.01	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.005	5.60774496873
P-0002044-T01-IM3	P-0002044	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN, bone	NEGATIVE	34 cm	IMPACT341	5.102040816	0.5	0.14	CIN	12.17	SD	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	0.6416	5.60774496873
P-0002072-T01-IM3	P-0002072	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	NO	LN, bone	POSITIVE	Body	IMPACT341	1.020408163	0.26	0.17	CIN	7.3	SD	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.3777	1.12154899375
P-0002118-T01-IM3	P-0002118	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	T3N0	NO	NO	YES	ovary, rectum	UNKNOWN	Fallopian Tube/Ovary	IMPACT341	4.081632653	0.08	0.09	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	NA	NEG	DIPLOID	0.1243	4.48619597498
P-0002132-T01-IM3	P-0002132	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T4N2	NO	NO	NO	LN	UNKNOWN	Remnant	IMPACT341	1.020408163	0.1	0.24	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	-0.0147	1.12154899375
P-0002152-T01-IM3	P-0002152	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	YES	NONE	NEGATIVE	Body	IMPACT341	2.040816327	0.36	0.28	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.2188	2.24309798749
P-0002161-T01-IM3	P-0002161	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	T4N1	NO	NO	NO	NONE	NEGATIVE	Cardia	IMPACT341	5.102040816	0.55	0.12	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.1837	5.60774496873
P-0002171-T01-IM3	P-0002171	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	YES	NO	YES	NONE	NEGATIVE	Liver	IMPACT341	3.06122449	0.08	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.1	NEG	DIPLOID	0.0046	3.36464698124
P-0002192-T01-IM3	P-0002192	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	YES	NO	LN	UNKNOWN	GEJ	IMPACT341	11.2244898	7.29	0.28	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0037	12.3370389312
P-0002208-T01-IM3	P-0002208	PROSPECTIVE	OSH	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	NO	NO	NONE	NEGATIVE	GEJ	IMPACT341	2.040816327	3.41	0.18	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	17.65	POS	AMP	2.6839	2.24309798749
P-0002208-T02-IM5	P-0002208	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Metastasis	IV	YES	NO	NO	NONE	NEGATIVE	Liver	IMPACT410	5.660377358	1.68	0.36	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	17.65	POS	AMP	3.858	5.96139401238
P-0002208-T03-IM5	P-0002208	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	NO	NO	NONE	NEGATIVE	GEJ	IMPACT410	2.830188679	1.7	0.27	CIN	15.67	PR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	17.65	POS	AMP	3.8087	2.98069700619
P-0002428-T01-IM3	P-0002428	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	NONE	NEGATIVE	Body	IMPACT341	6.12244898	0	0.1	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0858	6.72929396248
P-0002454-T01-IM3	P-0002454	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N3Mx	NO	NO	NO	LN	NEGATIVE	GEJ	IMPACT341	5.102040816	1.53	0.34	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0731	5.60774496873
P-0002460-T01-IM3	P-0002460	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	NO	NO	NO	LN	UNKNOWN	GEJ	IMPACT341	3.06122449	1.41	0.25	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.5131	3.36464698124
P-0002465-T01-IM3	P-0002465	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Metastasis	IV	YES	NO	NO	LN	UNKNOWN	Liver	IMPACT341	11.2244898	2.84	0.32	CIN	NA	NA	NA	NA	DOD	Combination	POD	NEGATIVE	positive	1	IHC 2+	1.9	NEG	DIPLOID	0.3164	12.3370389312
P-0002468-T01-IM3	P-0002468	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	YES	NO	YES	NONE	UNKNOWN	Fallopian Tube/Ovary	IMPACT341	3.06122449	0.21	0.26	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.2312	3.36464698124
P-0002482-T01-IM3	P-0002482	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	T4bN3a	NO	NO	YES	Ovary	NEGATIVE	Fallopian Tube/Ovary	IMPACT341	5.102040816	0	0.02	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0307	5.60774496873
P-0002495-T01-IM3	P-0002495	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T4aN3	NO	NO	YES	NONE	NEGATIVE	Distal	IMPACT341	2.040816327	0	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	1.1	NEG	DIPLOID	0.01	2.24309798749
P-0002549-T01-IM3	P-0002549	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	YES	NONE	NEGATIVE	Body	IMPACT341	8.163265306	0.08	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0478	8.97239194997
P-0002553-T01-IM3	P-0002553	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	Ovary	NEGATIVE	Distal	IMPACT341	1.020408163	0.09	0	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0105	1.12154899375
P-0002710-T01-IM3	P-0002710	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	NO	NO	LN	NEGATIVE	GEJ	IMPACT341	8.163265306	1.37	0.24	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.7639	8.97239194997
P-0002712-T01-IM3	P-0002712	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N1	NO	NO	YES	NONE	UNKNOWN	GEJ	IMPACT341	3.06122449	0	0.02	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0195	3.36464698124
P-0002737-T02-IM5	P-0002737	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	T2aN1	NO	NO	NO	LN	NEGATIVE	GEJ	IMPACT410	5.660377358	0.1	0.03	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0225	5.96139401238
P-0002743-T01-IM3	P-0002743	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T2bN1	YES	NO	NO	NONE	NEGATIVE	Remnant	IMPACT341	5.102040816	0.35	0.11	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.0565	5.60774496873
P-0002801-T01-IM3	P-0002801	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N2	NO	YES	NO	NONE	UNKNOWN	GEJ	IMPACT341	8.163265306	0.39	0.11	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.4775	8.97239194997
P-0002845-T01-IM3	P-0002845	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	NO	LN	UNKNOWN	Cardia	IMPACT341	5.102040816	0.37	0.26	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.1139	5.60774496873
P-0002883-T02-IM5	P-0002883	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN	NEGATIVE	GEJ	IMPACT410	7.547169811	0.57	0.27	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.9633	7.94852534983
P-0003027-T01-IM3	P-0003027	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	NO	bone, adnexa	POSITIVE	Fallopian Tube/Ovary	IMPACT341	1.020408163	0	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.0215	1.12154899375
P-0003048-T01-IM3	P-0003048	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	unknown	YES	NO	NO	NONE	NEGATIVE	Liver	IMPACT341	8.163265306	0.08	0.08	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	NA	8.97239194997
P-0003078-T01-IM5	P-0003078	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	NO	NO	adrenal	UNKNOWN	GEJ	IMPACT410	7.547169811	0.76	0.33	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.1142	7.94852534983
P-0003231-T01-IM5	P-0003231	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T3N0	NO	NO	YES	LN	NEGATIVE	Body	IMPACT410	0.943396226	0	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0199	0.993565668729
P-0003248-T01-IM5	P-0003248	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	NO	NO	LN	UNKNOWN	GEJ	IMPACT410	0.943396226	0	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.0102	0.993565668729
P-0003426-T01-IM5	P-0003426	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	YES	NONE	NEGATIVE	Distal	IMPACT410	0.943396226	0.34	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.0054	0.993565668729
P-0003432-T01-IM5	P-0003432	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	T1bN0	NO	NO	YES	bone	UNKNOWN	Manubrium	IMPACT410	4.716981132	0.77	0.39	CIN	NA	NA	NA	NA	DOD	Monotherapy	POD	INSUFFICIENT TISSUE	negative	0	N/A	NA	NEG	DIPLOID	-0.0627	4.96782834365
P-0003466-T01-IM5	P-0003466	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T3N1M0	NO	NO	NO	NONE	POSITIVE	Body	IMPACT410	8.490566038	1.38	0.23	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	4.3585	8.94209101856
P-0003477-T01-IM5	P-0003477	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN, adrenal	UNKNOWN	GEJ	IMPACT410	3.773584906	0.17	0.28	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.2086	3.97426267492
P-0003516-T01-IM5	P-0003516	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	NO	LN, bone	POSITIVE	Body	IMPACT410	0.943396226	0	0.05	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.4541	0.993565668729
P-0003536-T01-IM5	P-0003536	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	T1N0	NO	YES	NO	NONE	UNKNOWN	Lung	IMPACT410	5.660377358	1.08	0.5	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	2.495	5.96139401238
P-0003536-T02-IM5	P-0003536	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T1N0	NO	YES	NO	NONE	UNKNOWN	GEJ	IMPACT410	6.603773585	0.33	0.22	CIN	8.77	PR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	4.3658	6.95495968111
P-0003547-T01-IM5	P-0003547	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	YES	NO	LN	UNKNOWN	GEJ	IMPACT410	2.830188679	0.24	0.13	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.0932	2.98069700619
P-0003630-T01-IM5	P-0003630	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T1N0	NO	YES	YES	brain	NEGATIVE	GEJ	IMPACT410	0.943396226	1.18	0.42	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.2111	0.993565668729
P-0003630-T02-IM5	P-0003630	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T1N0	NO	YES	YES	brain	NEGATIVE	GEJ	IMPACT410	1.886792453	0	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.0207	1.98713133746
P-0003650-T01-IM5	P-0003650	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	NO	spleen	NEGATIVE	Body	IMPACT410	59.43396226	23.4	0.02	MSI	NA	NA	NA	NA	AWD	Monotherapy	CR	NOT TESTED	not tested	1	IHC 0+	NA	NEG	DIPLOID	0.0107	62.5946371299
P-0003679-T01-IM5	P-0003679	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	NO	NO	NO	LN	NEGATIVE	GEJ	IMPACT410	6.603773585	0.18	0.09	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0237	6.95495968111
P-0003713-T01-IM5	P-0003713	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	NO	brain	NEGATIVE	Cardia	IMPACT410	6.603773585	1.17	0.35	CIN	26.23	CR	AWD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	5.9	POS	AMP	3.9367	6.95495968111
P-0003875-T01-IM5	P-0003875	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	YES	YES	YES	LN, pancreas, adrenal, kidneys, bones	NEGATIVE	Fallopian Tube/Ovary	IMPACT410	5.660377358	0.7	0.39	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.2	NEG	DIPLOID	-0.0008	5.96139401238
P-0003892-T01-IM5	P-0003892	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	YES	Ovary	UNKNOWN	Fallopian Tube/Ovary	IMPACT410	2.830188679	0.16	0.02	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0382	2.98069700619
P-0003894-T01-IM5	P-0003894	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	bone, subcutaneous	UNKNOWN	Mid	IMPACT410	11.32075472	0.58	0.38	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.3739	11.9227880248
P-0003914-T01-IM3	P-0003914	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	YES	NO	LN	UNKNOWN	GEJ	IMPACT341	8.163265306	0.24	0.02	GS	6.5	SD	DOD	OFF TREATMENT	DOD	Monotherapy	POD	INSUFFICIENT TISSUE	BMS tested?	0	IHC 3+	NA	POS	DIPLOID	0.0582	8.97239194997
P-0003915-T01-IM3	P-0003915	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	NONE	NEGATIVE	Body	IMPACT341	6.12244898	0	0.04	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	-0.1033	6.72929396248
P-0003930-T01-IM3	P-0003930	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	LN	NEGATIVE	Distal	IMPACT341	6.12244898	1.5	0.15	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0694	6.72929396248
P-0003944-T01-IM3	P-0003944	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	NO	LN	UNKNOWN	Distal	IMPACT341	5.102040816	1.66	0.57	CIN	NA	NA	NA	NA	DOD	Monotherapy	POD	NOT TESTED	not tested	0	IHC 0+	NA	NEG	DIPLOID	0.3060556	5.60774496873
P-0003981-T01-IM3	P-0003981	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N1	YES	NO	NO	LN, bone	UNKNOWN	GEJ	IMPACT341	5.102040816	0.44	0.48	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	2	POS	AMP	1.1959	5.60774496873
P-0003983-T01-IM3	P-0003983	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	YES	LN	NEGATIVE	Cardia	IMPACT341	11.2244898	0.08	0.03	CIN	29.77	PR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	1.2095	12.3370389312
P-0004016-T01-IM5	P-0004016	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	YES	NO	LN, brain	UNKNOWN	GEJ	IMPACT410	4.716981132	0.45	0.31	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.5	NEG	DIPLOID	0.6603	4.96782834365
P-0004025-T01-IM5	P-0004025	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	NONE	NEGATIVE	Body	IMPACT410	4.716981132	0.09	0.04	CIN	6.13	SD	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	0.8726	4.96782834365
P-0004043-T01-IM3	P-0004043	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T3N3b	YES	YES	NO	LN, adrenal	POSITIVE	Distal	IMPACT341	5.102040816	0.86	0.23	CIN	11.37	PR	DOD	OFF TREATMENT	DOD	Monotherapy	POD	NOT TESTED	not tested	0	IHC 3+	NA	POS	AMP	4.452	5.60774496873
P-0004044-T01-IM3	P-0004044	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	YES	NO	LN, bone	UNKNOWN	Distal	IMPACT341	5.102040816	0.09	0.08	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	2.0107	5.60774496873
P-0004046-T01-IM3	P-0004046	PROSPECTIVE	OSH	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	NO	NO	NONE	POSITIVE	Distal	IMPACT341	11.2244898	0.93	0.03	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.5871	12.3370389312
P-0004076-T01-IM5	P-0004076	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N0	NO	NO	NO	LN	NEGATIVE	GEJ	IMPACT410	50	28.46	0.02	MSI	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.3	NEG	DIPLOID	-0.0563	52.6589804427
P-0004086-T01-IM5	P-0004086	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	YES	NO	LN	NEGATIVE	Lung	IMPACT410	4.716981132	0.25	0.01	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	DIPLOID	0.1399	4.96782834365
P-0004116-T01-IM5	P-0004116	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	YES	NO	LN	NEGATIVE	GEJ	IMPACT410	13.20754717	0.55	0.24	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.988	13.9099193622
P-0004244-T01-IM5	P-0004244	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	NONE	NEGATIVE	Body	IMPACT410	1.886792453	0	0	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0032	1.98713133746
P-0004268-T01-IM5	P-0004268	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	NO	NO	YES	LN	UNKNOWN	GEJ	IMPACT410	5.660377358	0.47	0.06	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	-0.0644	5.96139401238
P-0004326-T01-IM5	P-0004326	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	NONE	UNKNOWN	Body	IMPACT410	3.773584906	0.58	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0343	3.97426267492
P-0004407-T01-IM5	P-0004407	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	NONE	POSITIVE	Distal	IMPACT410	5.660377358	0.17	0.11	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	DIPLOID	-0.0166	5.96139401238
P-0004533-T01-IM5	P-0004533	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T4aN3b	NO	NO	NO	Ovary	NEGATIVE	Body	IMPACT410	3.773584906	0	0.01	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	-0.0181	3.97426267492
P-0004536-T01-IM5	P-0004536	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	NO	NO	NONE	NEGATIVE	GEJ	IMPACT410	0.943396226	0.13	0.17	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	AMP	2.6426	0.993565668729
P-0004541-T01-IM5	P-0004541	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	NO	NO	YES	NONE	NEGATIVE	GEJ	IMPACT410	3.773584906	0	0.17	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0429	3.97426267492
P-0004551-T01-IM5	P-0004551	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	T3N0	YES	NO	YES	NONE	NEGATIVE	Falciform	IMPACT410	2.830188679	0	0	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.4	NEG	DIPLOID	0.0178	2.98069700619
P-0004552-T01-IM5	P-0004552	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	NO	LN	NEGATIVE	Lymph Nodes	IMPACT410	1.886792453	1.89	0.58	CIN	NA	NA	NA	NA	DOD	Combination	PR	INSUFFICIENT TISSUE	positive	0	IHC 0+	NA	NEG	DIPLOID	0.0312	1.98713133746
P-0004605-T01-IM5	P-0004605	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	YES	NO	NONE	UNKNOWN	GEJ	IMPACT410	5.660377358	1.48	0.45	CIN	10	PR	AWD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 2+	4	POS	AMP	1.2654	5.96139401238
P-0004605-T02-IM5	P-0004605	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	NO	YES	NO	NONE	UNKNOWN	Lung	IMPACT410	10.37735849	4.84	0.59	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	3.2	POS	AMP	1.7896593	10.929222356
P-0004616-T01-IM5	P-0004616	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	TxN2	NO	NO	YES	PSOAS	UNKNOWN	GEJ	IMPACT410	8.490566038	1.59	0.2	CIN	2.5	POD	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	DIPLOID	0.1274	8.94209101856
P-0004647-T01-IM5	P-0004647	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	YES	NO	NO	NONE	POSITIVE	Liver	IMPACT410	9.433962264	0	0.06	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.7	NEG	DIPLOID	0.3802	9.93565668729
P-0004680-T01-IM5	P-0004680	PROSPECTIVE	OSH	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Metastasis	IV	YES	YES	NO	LN	UNKNOWN	Liver	IMPACT410	0	0.6	0.17	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	2.37	0.0
P-0004680-T02-IM5	P-0004680	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Metastasis	IV	YES	YES	NO	LN	UNKNOWN	Liver	IMPACT410	0	0.39	0.23	CIN	8.4	PR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.1228	0.0
P-0004689-T01-IM5	P-0004689	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	YES	NO	LN, bone	POSITIVE	Distal	IMPACT410	5.660377358	0	0.01	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0183	5.96139401238
P-0004958-T01-IM5	P-0004958	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	NO	NO	LN	NEGATIVE	GEJ	IMPACT410	3.773584906	0.84	0.19	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0755	3.97426267492
P-0004998-T01-IM5	P-0004998	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	NO	LN	NEGATIVE	Distal	IMPACT410	8.490566038	1.2	0.2	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.138	8.94209101856
P-0005019-T01-IM5	P-0005019	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	NO	PLEURAL FLUID	NEGATIVE	Cardia	IMPACT410	5.660377358	1.26	0.42	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	AMP	3.4756	5.96139401238
P-0005060-T01-IM5	P-0005060	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	YES	NONE	POSITIVE	Omental nodule	IMPACT410	2.830188679	0.92	0.29	CIN	8.07	SD	NED	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 2+	5	POS	AMP	1.9004556	2.98069700619
P-0005106-T01-IM5	P-0005106	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	NO	NO	LN	POSITIVE	GEJ	IMPACT410	7.547169811	2.61	0.51	CIN	15.7	SD	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	AMP	2.026	7.94852534983
P-0005167-T01-IM5	P-0005167	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	NO	LN	NEGATIVE	Cardia	IMPACT410	5.660377358	0.24	0.09	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0036	5.96139401238
P-0005168-T01-IM5	P-0005168	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	YES	NONE	NEGATIVE	Peritoneum	IMPACT410	2.830188679	0	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	-0.007	2.98069700619
P-0005300-T01-IM5	P-0005300	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N0M0	NO	NO	NO	SPLEEN	NEGATIVE	GEJ	IMPACT410	4.716981132	0.84	0.14	CIN	10.03	PR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	N/A	11.5	NEG	AMP	4.5928	4.96782834365
P-0005312-T01-IM5	P-0005312	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	YES	NO	LN	NEGATIVE	GEJ	IMPACT410	36.79245283	27.99	0.43	MSI	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.2509	38.7490610804
P-0005431-T01-IM5	P-0005431	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	NO	NONE	NEGATIVE	Body	IMPACT410	0.943396226	0	0.08	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	1.1	NEG	DIPLOID	0.0473	0.993565668729
P-0005488-T01-IM5	P-0005488	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	NO	NO	LN, bone	NEGATIVE	GEJ	IMPACT410	10.37735849	0.41	0.41	CIN	NA	NA	NA	NA	AWD	Combination	POD	NOT TESTED	not tested	1	IHC 1+	NA	NEG	AMP	0.9224	10.929222356
P-0005500-T01-IM5	P-0005500	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N1	NO	NO	NO	LN, skin	NEGATIVE	GEJ	IMPACT410	22.64150943	3.78	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0739	23.8455760495
P-0005618-T02-IM5	P-0005618	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	NO	NO	NONE	NEGATIVE	GEJ	IMPACT410	10.37735849	0.07	0.06	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	1.6362	10.929222356
P-0005637-T01-IM5	P-0005637	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	ypT1bN2	NO	NO	NO	LN	NEGATIVE	Cardia	IMPACT410	1.886792453	1.26	0.23	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1	NEG	DIPLOID	-0.1317	1.98713133746
P-0005683-T01-IM5	P-0005683	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	NONE	POSITIVE	Distal	IMPACT410	7.547169811	1.01	0.22	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0661	7.94852534983
P-0005702-T01-IM5	P-0005702	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	YES	YES	LN, ovary	NEGATIVE	Cardia	IMPACT410	0.943396226	0.08	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	DIPLOID	0.0658	0.993565668729
P-0005709-T01-IM5	P-0005709	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	YES	NO	NO	NONE	NEGATIVE	Liver	IMPACT410	0.943396226	0.17	0	CIN	23.37	SD	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	0.9923	0.993565668729
P-0005736-T01-IM5	P-0005736	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	YES	NONE	NEGATIVE	Liver	IMPACT410	4.716981132	0.45	0.07	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0727	4.96782834365
P-0005767-T02-IM5	P-0005767	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	YES	NO	NONE	UNKNOWN	GEJ	IMPACT410	6.603773585	0.45	0.33	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.0003	6.95495968111
P-0005819-T01-IM5	P-0005819	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	T3N1	YES	NO	NO	NONE	NEGATIVE	Liver	IMPACT410	3.773584906	0.87	0.34	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.1167	3.97426267492
P-0005899-T01-IM5	P-0005899	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	pT2pN2	NO	YES	NO	anastomosis	NEGATIVE	GEJ	IMPACT410	7.547169811	0.65	0.19	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0758	7.94852534983
P-0005919-T01-IM5	P-0005919	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	T3N1	YES	NO	NO	NONE	UNKNOWN	GEJ	IMPACT410	7.547169811	NA	0.22	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.6	NEG	DIPLOID	0.3282	7.94852534983
P-0005930-T01-IM5	P-0005930	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	NONE	UNKNOWN	GEJ	IMPACT410	4.716981132	1.52	0.69	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.8	NEG	DIPLOID	0.5385	4.96782834365
P-0005991-T01-IM5	P-0005991	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	BONE, BRAIN	NEGATIVE	GEJ	IMPACT410	3.773584906	0.59	0.34	CIN	5.6	SD	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 2+	3.4	POS	DIPLOID	0.0431	3.97426267492
P-0005993-T01-IM5	P-0005993	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	YES	YES	NO	LN, bone	UNKNOWN	Lung	IMPACT410	4.716981132	1.56	0.49	CIN	23.8	PR	AWD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	4.8119	4.96782834365
P-0005995-T01-IM5	P-0005995	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	NO	NONE	POSITIVE	Body	IMPACT410	6.603773585	0	0.02	CIN	16.33	PR	AWD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	2.5704	6.95495968111
P-0005999-T01-IM5	P-0005999	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	NONE	NEGATIVE	Body	IMPACT410	0.943396226	0	0	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.5	NEG	DIPLOID	0.0601	0.993565668729
P-0006012-T01-IM5	P-0006012	PROSPECTIVE	OSH	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T2N1	NO	NO	NO	NONE	UNKNOWN	Cardia	IMPACT410	0.943396226	0.25	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0012	0.993565668729
P-0006026-T01-IM5	P-0006026	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	YES	YES	NONE	NEGATIVE	Falciform ligament	IMPACT410	6.603773585	0.39	0.08	CIN	NA	NA	NA	NA	AWD	Monotherapy	POD	NEGATIVE	not tested	0	IHC 0+	NA	NEG	DIPLOID	0.0972	6.95495968111
P-0006043-T01-IM5	P-0006043	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	T2N1M0	NO	NO	NO	LN, bone	POSITIVE	Lung	IMPACT410	0.943396226	0.08	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0526	0.993565668729
P-0006112-T01-IM5	P-0006112	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	NO	NO	abdominal LN, spleen	UNKNOWN	Body	IMPACT410	5.660377358	0.15	0.21	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.9735926	5.96139401238
P-0006112-T02-IM5	P-0006112	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	NO	NO	abdominal LN, spleen	UNKNOWN	Body	IMPACT410	2.830188679	1.06	0.43	CIN	7.87	SD	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	2.4022	2.98069700619
P-0006318-T01-IM5	P-0006318	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	YES	LN, ovary, omentum	UNKNOWN	Ovary	IMPACT410	0.943396226	0	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0127	0.993565668729
P-0006333-T01-IM5	P-0006333	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	YES	NO	NONE	NEGATIVE	GEJ	IMPACT410	2.830188679	0.16	0.15	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.2208	2.98069700619
P-0006357-T01-IM5	P-0006357	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN	NEGATIVE	GEJ	IMPACT410	4.716981132	0.89	0.3	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.2297	4.96782834365
P-0006448-T01-IM5	P-0006448	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	YES	YES	LN	NEGATIVE	GEJ	IMPACT410	7.547169811	1.55	0.38	CIN	16.57	PR	AWD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	AMP	3.251	8.94209101856
P-0006475-T01-IM5	P-0006475	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T4aN0	NO	NO	YES	LN	UNKNOWN	Distal	IMPACT410	4.716981132	0	0.02	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.0111	4.96782834365
P-0006519-T01-IM5	P-0006519	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	NO	NO	LN	UNKNOWN	GEJ	IMPACT410	6.603773585	0.82	0.08	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	2	POS	DIPLOID	0.1816	6.95495968111
P-0006615-T01-IM5	P-0006615	PROSPECTIVE	OSH	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	NO	NO	NO	LN	NEGATIVE	Pleural fluid	IMPACT410	4.716981132	1.57	0.38	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.1287	4.96782834365
P-0006699-T01-IM5	P-0006699	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	T3N1M0	NO	NO	YES	NONE	UNKNOWN	Peritoneum	IMPACT410	6.603773585	0.07	0.14	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.1595	6.95495968111
P-0006700-T01-IM5	P-0006700	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	YES	YES	NONE	POSITIVE	Lymph Nodes	IMPACT410	10.37735849	0.49	0.11	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.4198	10.929222356
P-0006732-T01-IM5	P-0006732	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T2N0M0	NO	NO	NO	LN	NEGATIVE	GEJ	IMPACT410	3.773584906	0.35	0.05	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0479	3.97426267492
P-0006752-T01-IM5	P-0006752	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T1bN0	NO	NO	NO	LN	UNKNOWN	Distal	IMPACT410	38.67924528	12.61	0.02	MSI	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.3535	40.7361924179
P-0006836-T01-IM5	P-0006836	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	NO	YES	NO	LN, bone, pleura, adrenal gland, bilateral adnexa	POSITIVE	GEJ	IMPACT410	5.660377358	0.08	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0692	5.96139401238
P-0006838-T01-IM5	P-0006838	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	T2N0M0	YES	NO	NO	NONE	UNKNOWN	Body	IMPACT410	11.32075472	2.54	0.43	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.2873	10.929222356
P-0006869-T01-IM5	P-0006869	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	YES	NONE	NEGATIVE	Upper quadrant washings	IMPACT410	1.886792453	2.17	0.28	CIN	NA	NA	NA	NA	DOD	Monotherapy	POD	NOT TESTED	negative	0	IHC 0+	NA	NEG	DIPLOID	0.0062	1.98713133746
P-0006877-T01-IM5	P-0006877	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	NO	YES	NONE	UNKNOWN	GEJ	IMPACT410	10.37735849	0.78	0.26	CIN	2.8	SD	LTF	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	0.9512	10.929222356
P-0006911-T02-IM5	P-0006911	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T2N2M0	YES	YES	YES	NONE	UNKNOWN	Distal	IMPACT410	2.830188679	0.09	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.0279	2.98069700619
P-0006919-T01-IM5	P-0006919	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	NONE	NEGATIVE	GEJ	IMPACT410	0.943396226	0.09	0.23	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.1327	0.993565668729
P-0007164-T01-IM5	P-0007164	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N2	NO	NO	YES	BONE	NEGATIVE	GEJ	IMPACT410	5.660377358	0	0.01	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0931	5.96139401238
P-0007227-T01-IM5	P-0007227	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	YES	YES	NONE	NEGATIVE	GEJ	IMPACT410	1.886792453	0	0.18	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.2	NEG	DIPLOID	0.2768	1.98713133746
P-0007227-T02-IM5	P-0007227	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	YES	YES	YES	NONE	NEGATIVE	Peritoneum	IMPACT410	0.943396226	0.1	0.05	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.2	NEG	DIPLOID	0.0646	0.993565668729
P-0007386-T01-IM5	P-0007386	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	NO	LN	UNKNOWN	Body	IMPACT410	5.660377358	0.58	0.05	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0025	5.96139401238
P-0007412-T01-IM5	P-0007412	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T3N3a	NO	NO	NO	LN	UNKNOWN	not sure	IMPACT410	1.886792453	0	0.04	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	DIPLOID	0.0142	1.98713133746
P-0007531-T01-IM5	P-0007531	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	NO	thoracic, abdominal, and retroperitoneal LN	NEGATIVE	Body	IMPACT410	9.433962264	0	0.03	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0221	9.93565668729
P-0007531-T02-IM5	P-0007531	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	NO	thoracic, abdominal, and retroperitoneal LN	NEGATIVE	Body	IMPACT410	12.26415094	0	0.01	GS	NA	NA	NA	NA	DOD	Combination	PR	NEGATIVE	positive	1	IHC 0+	NA	NEG	DIPLOID	0.0362	12.9163536935
P-0007572-T01-IM5	P-0007572	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	YES	NO	LN, bone	NEGATIVE	GEJ	IMPACT410	8.490566038	0.24	0.03	CIN	8.07	PR	LTF	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	2.7704	8.94209101856
P-0007598-T01-IM5	P-0007598	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	YES	NO	NO	LN, bone	NEGATIVE	Retroperitoneum	IMPACT410	4.716981132	0.89	0.1	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	-0.0116	4.96782834365
P-0007653-T01-IM5	P-0007653	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N1M0	NO	NO	NO	LN	UNKNOWN	GEJ	IMPACT410	0.943396226	0	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	DIPLOID	0.0511	0.993565668729
P-0007748-T01-IM5	P-0007748	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	NO	NO	YES	NONE	NEGATIVE	Peritoneum	IMPACT410	1.886792453	0	0.13	CIN	NA	NA	NA	NA	DOD	Combination	POD	NEGATIVE	not tested	0	IHC 2+	1.5	NEG	DIPLOID	-0.0003	1.98713133746
P-0007845-T01-IM5	P-0007845	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N2	NO	NO	NO	LN	NEGATIVE	GEJ	IMPACT410	1.886792453	0.66	0.16	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.119	1.98713133746
P-0007895-T01-IM5	P-0007895	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN	UNKNOWN	GEJ	IMPACT410	3.773584906	0.71	0.17	CIN	9.87	PR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 2+	1.5	NEG	AMP	1.1414	3.97426267492
P-0007995-T01-IM5	P-0007995	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Metastasis	IV	NO	NO	NO	LN	NEGATIVE	Lymph Nodes	IMPACT410	28.30188679	20.74	0.09	MSI	NA	NA	NA	NA	AWD	Monotherapy	CR	NEGATIVE	positive	1	IHC 0+	NA	NEG	DIPLOID	-0.0011	29.8069700619
P-0007995-T02-IM5	P-0007995	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	NO	NO	NO	LN	NEGATIVE	GEJ	IMPACT410	31.13207547	16.74	0.04	MSI	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0237	32.7876670681
P-0008004-T01-IM5	P-0008004	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Metastasis	uT3N1	NO	YES	NO	NONE	NEGATIVE	Lung	IMPACT410	1.886792453	0	0	CIN	NA	NA	NA	NA	DOD	Monotherapy	POD	NEGATIVE	positive	0	IHC 0+	NA	NEG	DIPLOID	-0.0351	1.98713133746
P-0008039-T01-IM5	P-0008039	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	LN	NEGATIVE	Distal	IMPACT410	2.830188679	0.09	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0242	2.98069700619
P-0008187-T01-IM5	P-0008187	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	pT4aN0	YES	NO	NO	LN	UNKNOWN	Body	IMPACT410	5.660377358	3.26	0.49	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.1535	5.96139401238
P-0008188-T01-IM5	P-0008188	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	NO	LN	NEGATIVE	Distal	IMPACT410	45.28301887	14.78	0.01	MSI	NA	NA	NA	NA	DOD	Monotherapy	POD	NOT TESTED	positive	1	N/A	NA	NEG	DIPLOID	0.0013	47.691152099
P-0008271-T01-IM5	P-0008271	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	NO	NO	LN	UNKNOWN	GEJ	IMPACT410	6.603773585	1.25	0.32	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0524	6.95495968111
P-0008305-T01-IM5	P-0008305	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T1bN2	NO	NO	NO	bone	NEGATIVE	distal	IMPACT410	2.830188679	0.08	0.16	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.1422	2.98069700619
P-0008318-T01-IM5	P-0008318	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T2N0	NO	NO	NO	LN	UNKNOWN	GEJ	IMPACT410	1.886792453	0	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.0218	1.98713133746
P-0008417-T01-IM5	P-0008417	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	NO	LN	NEGATIVE	Distal	IMPACT410	10.37735849	1.83	0.01	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	0.3969	10.929222356
P-0008536-T02-IM5	P-0008536	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	YES	YES	LN, spleen	NEGATIVE	GEJ	IMPACT410	4.716981132	2.34	0.58	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	-0.2022	4.96782834365
P-0008788-T01-IM5	P-0008788	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	T2N1	NO	NO	NO	LN, adrenal, pleura, omentum	NEGATIVE	Pleural nodule	IMPACT410	7.547169811	0	0.2	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0892	7.94852534983
P-0008809-T01-IM5	P-0008809	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T4aN3a	NO	NO	NO	bone	POSITIVE	Stomach	IMPACT410	0.943396226	0	0.0027	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0527	0.993565668729
P-0008844-T01-IM5	P-0008844	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	NONE	NEGATIVE	Body	IMPACT410	5.660377358	0	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0068	5.96139401238
P-0008882-T01-IM5	P-0008882	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	NONE	POSITIVE	Distal	IMPACT410	0.943396226	0.08	0	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.0841	0.993565668729
P-0008926-T01-IM5	P-0008926	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	NO	NO	LN	NEGATIVE	GEJ	IMPACT410	1.886792453	0	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.0109	1.98713133746
P-0008956-T01-IM5	P-0008956	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	NO	LN	UNKNOWN	Distal	IMPACT410	10.37735849	0.17	0.05	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.3466	10.929222356
P-0009055-T01-IM5	P-0009055	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	NO	NO	NONE	UNKNOWN	GEJ	IMPACT410	7.547169811	0.16	0.03	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	-0.0267	7.94852534983
P-0009057-T01-IM5	P-0009057	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	YES	Ovary	UNKNOWN	Fallopian Tube/Ovary	IMPACT410	40.56603774	34.51	0	MSI	NA	NA	NA	NA	DOD	Monotherapy	SD	NEGATIVE	positive	1	IHC 0+	NA	NEG	DIPLOID	0.0191	42.7233237554
P-0009065-T01-IM5	P-0009065	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	YES	NO	LN	POSITIVE	GEJ	IMPACT410	0.943396226	1.96	0.12	CIN	19.97	PR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.2626	0.993565668729
P-0009065-T02-IM5	P-0009065	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	YES	NO	LN	POSITIVE	GEJ	IMPACT410	1.886792453	2.61	0.29	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.4072	1.98713133746
P-0009066-T01-IM5	P-0009066	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	pT2N1	NO	NO	YES	LN, RLQ	NEGATIVE	GEJ	IMPACT410	9.433962264	0.27	0.01	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1	NEG	DIPLOID	0.0448	9.93565668729
P-0009067-T01-IM5	P-0009067	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN, bone	NEGATIVE	GEJ	IMPACT410	4.716981132	0.08	0.19	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	-0.1611	4.96782834365
P-0009069-T01-IM5	P-0009069	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Metastasis	IV	YES	YES	NO	LN	UNKNOWN	Peritoneum	IMPACT410	0.943396226	0.17	0.01	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.0518	0.993565668729
P-0009088-T01-IM5	P-0009088	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	YES	NO	LN	NEGATIVE	GEJ	IMPACT410	4.716981132	0	0.01	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0198	4.96782834365
P-0009094-T01-IM5	P-0009094	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	T4aN2	NO	NO	NO	Ovary	NEGATIVE	Fallopian Tube/Ovary	IMPACT410	4.716981132	0	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0148	4.96782834365
P-0009100-T01-IM5	P-0009100	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	uT3Nx	NO	NO	YES	Brain	NEGATIVE	Cardia	IMPACT410	2.830188679	0.3	0.17	CIN	NA	NA	NA	NA	DOD	Monotherapy	POD	NEGATIVE	not tested	0	IHC 0+	NA	NEG	DIPLOID	-0.025	2.98069700619
P-0009159-T02-IM5	P-0009159	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T4aN1	NO	NO	YES	NONE	UNKNOWN	Body	IMPACT410	1.886792453	0.16	0.17	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0766	1.98713133746
P-0009257-T01-IM5	P-0009257	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	NO	LN, ovary	NEGATIVE	Distal	IMPACT410	1.886792453	0.44	0.01	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	-0.0098	1.98713133746
P-0009337-T01-IM5	P-0009337	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	YES	NO	NONE	UNKNOWN	Distal	IMPACT410	3.773584906	0.85	0.04	CIN	NA	NA	NA	NA	DOD	Monotherapy	POD	NOT TESTED	not tested	0	N/A	NA	NEG	DIPLOID	0.1585	3.97426267492
P-0009368-T01-IM5	P-0009368	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	NO	LN	UNKNOWN	Cardia	IMPACT410	1.886792453	0.39	0.17	EBV	NA	NA	NA	NA	AWD	Combination	CR	POSITIVE	not evaluable	0	IHC 0+	NA	NEG	DIPLOID	0.041	1.98713133746
P-0009400-T01-IM5	P-0009400	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N2	NO	NO	NO	LN, pleura, sternum	NEGATIVE	GEJ	IMPACT410	3.773584906	0.19	0.32	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.09	3.97426267492
P-0009563-T01-IM5	P-0009563	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN	NEGATIVE	GEJ	IMPACT410	6.603773585	3.01	0.2	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1	NEG	DIPLOID	-0.0257	6.95495968111
P-0009607-T01-IM5	P-0009607	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	T3/4aN0	NO	NO	NO	LN, ovary	NEGATIVE	Fallopian Tube/Ovary	IMPACT410	3.773584906	0	0.14	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.1573	3.97426267492
P-0009631-T01-IM5	P-0009631	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN	NEGATIVE	GEJ	IMPACT410	3.773584906	0.3	0.24	CIN	9.13	SD	AWD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.7006	3.97426267492
P-0009637-T01-IM5	P-0009637	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N+	NO	NO	YES	LN	POSITIVE	GEJ	IMPACT410	3.773584906	0	0.01	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0098	3.97426267492
P-0009739-T01-IM5	P-0009739	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N1	NO	YES	NO	Pleura	UNKNOWN	GEJ	IMPACT410	3.773584906	0.46	0.22	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.106	2.98069700619
P-0009868-T01-IM5	P-0009868	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	YES	NO	LN, Pleura	NEGATIVE	Cardia	IMPACT410	3.773584906	2.77	0.4	CIN	18.93	PR	AWD	ON TREATMENT	NA	NA	NA	NA	NA	NA	N/A	8.6	NEG	AMP	4.1988778	3.97426267492
P-0009872-T01-IM5	P-0009872	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	YES	NO	LN	NEGATIVE	Mid	IMPACT410	4.716981132	2.16	0.27	CIN	8.83	PR	LTF	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	2.2954	4.96782834365
P-0009872-T02-IM5	P-0009872	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	YES	YES	NO	LN	NEGATIVE	Lung	IMPACT410	6.603773585	1	0.19	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.4038	6.95495968111
P-0009918-T01-IM5	P-0009918	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T4aN1	NO	NO	YES	NONE	POSITIVE	Body	IMPACT410	59.43396226	37.97	0.02	MSI	NA	NA	NA	NA	AWD	Monotherapy	CR	NEGATIVE	positive	1	IHC 2+	1.1	NEG	DIPLOID	0.0546	62.5946371299
P-0010197-T01-IM5	P-0010197	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	YES	NONE	NEGATIVE	Peritoneum	IMPACT410	6.603773585	0.47	0.22	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0572	6.95495968111
P-0010220-T01-IM5	P-0010220	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN, bone	NEGATIVE	distal	IMPACT410	6.603773585	2.15	0.24	CIN	16.27	PR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	2	POS	AMP	1.0565	6.95495968111
P-0010313-T01-IM5	P-0010313	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	NONE	UNKNOWN	GEJ	IMPACT410	4.716981132	0.17	0.31	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0336	4.96782834365
P-0010317-T01-IM5	P-0010317	PROSPECTIVE	OSH	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N1	NO	YES	NO	LN	NEGATIVE	GEJ	IMPACT410	2.830188679	2.52	0.48	CIN	NA	NA	NA	NA	DOD	Monotherapy	POD	NOT TESTED	negative	0	IHC 0+	NA	NEG	DIPLOID	0.2083	2.98069700619
P-0010501-T01-IM5	P-0010501	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	YES	YES	NONE	UNKNOWN	Peritoneum	IMPACT410	9.433962264	0	0.03	GS	NA	NA	NA	NA	DOD	Monotherapy	POD	NEGATIVE	not tested	0	IHC 0+	NA	NEG	DIPLOID	0.0669	9.93565668729
P-0010827-T01-IM5	P-0010827	PROSPECTIVE	OSH	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	NO	YES	NO	NONE	UNKNOWN	Lung	IMPACT410	7.547169811	0.96	0.1	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	AMP	4.0773	7.94852534983
P-0011175-T01-IM5	P-0011175	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	NO	NONE	UNKNOWN	body	IMPACT410	5.660377358	0.08	0.04	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.9	NEG	DIPLOID	0.0351	5.96139401238
P-0011284-T01-IM5	P-0011284	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN	UNKNOWN	GEJ	IMPACT410	6.603773585	0.75	0.25	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.1	NEG	DIPLOID	0.0903	6.95495968111
P-0011328-T01-IM5	P-0011328	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	T3N1	NO	NO	NO	adrenal	UNKNOWN	Adrenal mass	IMPACT410	11.32075472	1.89	0.62	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0578	11.9227880248
P-0012339-T01-IM5	P-0012339	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T3N0M0	NO	NO	YES	NONE	UNKNOWN	wall	IMPACT410	3.773584906	0	0.0045	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0209	3.97426267492
P-0012627-T01-IM5	P-0012627	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	YES	NO	LN	UNKNOWN	GEJ	IMPACT410	8.490566038	0.32	0.31	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0764	8.94209101856
P-0012720-T01-IM5	P-0012720	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	NO	YES	LN, gallbladder	UNKNOWN	lower third	IMPACT410	2.830188679	1.37	0.34	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.17	2.98069700619
P-0013106-T01-IM5	P-0013106	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Metastasis	T4aN0M0	NO	NO	NO	LN	POSITIVE		IMPACT410	14.1509434	1.03	0.22	CIN	NA	NA	NA	NA	AWD	Monotherapy	CR	NOT TESTED	positive	1	IHC 0+	NA	NEG	DIPLOID	0.65	14.9034850309
P-0013270-T01-IM5	P-0013270	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	YES	YES	NO	LN	UNKNOWN	Liver	IMPACT410	2.830188679	2.08	0.64	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.2449	2.98069700619
P-0013302-T01-IM5	P-0013302	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	YES	NO	NO	LN	POSITIVE	Liver	IMPACT410	0.943396226	2.71	0.57	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.1064	0.993565668729
P-0013386-T01-IM5	P-0013386	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	NO	NONE	NEGATIVE		IMPACT410	2.830188679	0.13	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0639	2.98069700619
P-0013417-T01-IM5	P-0013417	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	NO	YES	NO	LN	UNKNOWN	Lung nodule	IMPACT410	2.830188679	0.07	0.02	CIN	13.2	PR	AWD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.0364	2.98069700619
P-0013879-T01-IM5	P-0013879	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	NONE	NEGATIVE	GEJ	IMPACT410	2.830188679	0.34	0.12	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0551	2.98069700619
P-0013973-T01-IM5	P-0013973	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	T3N1	NO	NO	NO	NONE	UNKNOWN	Adhesions	IMPACT410	2.830188679	0	0	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0754	2.98069700619
P-0014118-T01-IM5	P-0014118	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	YES	colon	NEGATIVE	Colon	IMPACT410	0	0	NA	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.0513	0.0
P-0014326-T01-IM6	P-0014326	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	NO	LN	UNKNOWN	Esophagus	IMPACT468	1.639344262	2.21	0.3	CIN	12.9	CR	AWD	ON TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	2.5	POS	AMP	1.1254	1.76563024171
P-0014327-T01-IM6	P-0014327	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	YES	NO	NO	NONE	UNKNOWN	Liver	IMPACT468	3.278688525	1.62	0.9	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	2	NEG	DIPLOID	0.7475	3.53126048343
P-0014424-T01-IM6	P-0014424	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	T3N1	NO	NO	NO	bones, soft tissue	UNKNOWN	Neck soft tissue	IMPACT468	4.918032787	1.18	0.09	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.1	NEG	DIPLOID	0.0064	5.29689072514
P-0014504-T01-IM6	P-0014504	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	NO	NO	NO	LN	UNKNOWN	Esophageal lesion	IMPACT468	6.557377049	0.38	0.31	CIN	12.97	PR	AWD	ON TREATMENT	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	AMP	3.1549	7.06252096686
P-0014672-T01-IM6	P-0014672	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	NO	LN	UNKNOWN	distal	IMPACT468	4.098360656	2.07	0.03	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0228	4.41407560429
P-0015202-T01-IM6	P-0015202	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	T3N1M0	NO	NO	NO	LN	UNKNOWN	GEJ	IMPACT468	7.37704918	1.05	0.16	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0347	7.94533608772
P-0015251-T01-IM6	P-0015251	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Metastasis	T3N0M0	YES	NO	NO	NONE	UNKNOWN	Liver	IMPACT468	8.196721311	1.55	0.6	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.2727	8.82815120857
P-0015331-T01-IM6	P-0015331	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	T3N1M0	YES	NO	NO	LN	NEGATIVE	Antrum	IMPACT468	16.39344262	1.24	0.25	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.1	NEG	DIPLOID	0.309	17.6563024171
P-0015641-T01-IM6	P-0015641	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N2M0	NO	NO	NO	brain	UNKNOWN	Distal	IMPACT468	3.278688525	0.69	0.27	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0462	3.53126048343
P-0015904-T01-IM6	P-0015904	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Metastasis	IV	YES	NO	NO	LN	UNKNOWN	LN	IMPACT468	10.6557377	0.73	0.49	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	1.3	NEG	DIPLOID	0.356	11.4765965711
P-0016008-T01-IM6	P-0016008	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	NO	NO	LN, bone	UNKNOWN	Distal	IMPACT468	4.098360656	1.66	0.43	CIN	17.1	SD	AWD	ON TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	5.2225	3.53126048343
P-0016020-T01-IM6	P-0016020	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	NO	NO	YES	LN	UNKNOWN	GEJ	IMPACT468	2.459016393	0.22	0.034	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0626	2.64844536257
P-0016069-T01-IM6	P-0016069	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T2N1M0	NO	NO	NO	LN	UNKNOWN	35	IMPACT468	4.098360656	0.38	0.22	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0784	4.41407560429
P-0016187-T01-IM6	P-0016187	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N1M0	NO	NO	NO	LN, RP mass	UNKNOWN	thoracic	IMPACT468	7.37704918	0.07	0.21	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 1+	NA	NEG	DIPLOID	0.107	7.94533608772
P-0016233-T01-IM6	P-0016233	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	NO	NO	YES	bone	NEGATIVE	Distal	IMPACT468	4.098360656	1.14	0.36	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	1.4	NEG	DIPLOID	0.086	4.41407560429
P-0016294-T01-IM6	P-0016294	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	pT3pN2	YES	NO	NO	NONE	UNKNOWN	GEJ	IMPACT468	0.819672131	0.2	0.001	GS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	1.6	NEG	DIPLOID	0.3701	0.882815120857
P-0016311-T01-IM6	P-0016311	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	NONE	NEGATIVE		IMPACT468	3.278688525	0	0.09	CIN	NA	NA	NA	NA	AWD	Monotherapy	PR	NEGATIVE	positive	0	IHC 0+	NA	NEG	DIPLOID	0.0814	3.53126048343
P-0016931-T01-IM6	P-0016931	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	YES	NO	NO	bone	NEGATIVE		IMPACT468	4.098360656	3.4	0.52	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.1359	4.41407560429
P-0017167-T01-IM6	P-0017167	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	LN, bone	NEGATIVE		IMPACT468	5.737704918	0.8	0.096	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	1.5	NEG	DIPLOID	0.1106	6.179705846
P-0017370-T01-IM6	P-0017370	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	NO	LN	NEGATIVE		IMPACT468	33.60655738	29.37	0.067	MSI	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.0191	37.078235076
P-0018439-T01-IM6	P-0018439	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	YES	NO	LN	UNKNOWN		IMPACT468	9.016393443	2.57	0.18	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	N/A	NA	NEG	DIPLOID	-0.0183	9.71096632943
P-0018464-T01-IM6	P-0018464	PROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Metastasis	ypT2N3Mx	NO	NO	NO	LN, bone	UNKNOWN		IMPACT468	5.737704918	0.13	0.19	CIN	NA	NA	NA	NA	AWD	Combination	PR	NEGATIVE	positive	0	IHC 2+	1.8	NEG	DIPLOID	0.1949	6.179705846
P-0018538-T01-IM6	P-0018538	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	YES	LN	UNKNOWN		IMPACT468	0.819672131	0.38	0.0069	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0108	0.882815120857
P-0018568-T01-IM6	P-0018568	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	YES	NO	NO	NONE	NEGATIVE		IMPACT468	4.918032787	0.4	0.37	CIN	7.13	PR	AWD	ON TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	1.6894407	5.29689072514
P-0018591-T01-IM6	P-0018591	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	NO	NO	YES	LN	POSITIVE		IMPACT468	4.918032787	0.07	0.0068	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.0336	2.64844536257
P-0018683-T01-IM6	P-0018683	PROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	NO	NO	LN	UNKNOWN		IMPACT468	5.737704918	0.17	0.037	CIN	6.03	SD	AWD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 2+	2	POS	DIPLOID	0.0571	6.179705846
P-0018714-T01-IM6	P-0018714	PROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	YES	LN	NEGATIVE		IMPACT468	3.278688525	0	0.16	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	-0.1377	3.53126048343
s_YJ_egc_040_M1	P-0000716	RETROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	YES	YES	NO	LN	UNKNOWN	Liver	IMPACT410	6.603773585	NA	0.34	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	2.6	POS	AMP	1.4303	13.9099193622
s_YJ_her_003_P1	YJ-her-003	RETROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	YES	NONE	UNKNOWN	Distal	IMPACT341	5.102040816	NA	0.23	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	4.3421	12.3370389312
s_YJ_her_003_P3	YJ-her-003	RETROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	YES	NO	YES	NONE	UNKNOWN	Umbilical nodule	IMPACT341	5.102040816	NA	0.24	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.9242	12.3370389312
s_YJ_her_008_M	YJ-her-008	RETROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	T3N0M0	YES	YES	NO	bone	NEGATIVE	Liver	IMPACT341	10.20408163	NA	0.32	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 2+	3.8	POS	AMP	1.1208	14.5801369187
s_YJ_her_008_P	YJ-her-008	RETROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N0M0	YES	YES	NO	bone	NEGATIVE	GEJ	IMPACT341	10.20408163	NA	0.19	CIN	5.9	PR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 2+	3.3	POS	AMP	0.4903	14.5801369187
s_YJ_her_009_M2	YJ-her-009	RETROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Metastasis	IV	YES	YES	YES	NONE	NEGATIVE	Perietal lesion	IMPACT341	16.32653061	NA	0.81	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	5.0873	32.5249208186
s_YJ_her_009_P	YJ-her-009	RETROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	GEJ	Primary	IV	YES	YES	YES	NONE	NEGATIVE	GEJ	IMPACT341	8.163265306	NA	0.09	CIN	13	PR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	0.6017	32.5249208186
s_YJ_her_010_P1	YJ-her-010	RETROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	YES	LN	NEGATIVE	Cardia	IMPACT341	4.081632653	NA	0.07	CIN	7.63	SD	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	2.4743	6.72929396248
s_YJ_her_010_P2	YJ-her-010	RETROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	YES	LN	NEGATIVE	Cardia	IMPACT341	6.12244898	NA	0.59	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 0+	NA	NEG	DIPLOID	0.229	6.72929396248
s_YJ_her_012_P1	YJ-her-012	RETROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	NO	NONE	NEGATIVE	GEJ	IMPACT341	4.081632653	NA	0.11	CIN	3.53	POD	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.9111	7.85084295622
s_YJ_her_012_P2	YJ-her-012	RETROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	YES	NO	NO	NONE	NEGATIVE	GEJ	IMPACT341	6.12244898	NA	0.58	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	2.1651	7.85084295622
s_YJ_her_013_P	YJ-her-013	RETROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N2	YES	NO	YES	NONE	NEGATIVE	GEJ	IMPACT341	2.040816327	NA	0.38	CIN	3.7	POD	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	0.8474	6.72929396248
s_YJ_her_013_X1	YJ-her-013	RETROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N2	YES	NO	YES	NONE	NEGATIVE	GEJ	IMPACT341	5.10204075	NA	0.27	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	1.2867	6.72929396248
s_YJ_her_014_M	YJ-her-014	RETROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	NO	NO	NO	LN, ovary, brain	UNKNOWN	Cerebellum	IMPACT341	5.102040816	NA	0.52	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	5.1823	7.85084295622
s_YJ_her_014_P	YJ-her-014	RETROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	NO	LN, ovary, brain	UNKNOWN	Body	IMPACT341	5.102040816	NA	0.33	CIN	18.27	PR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	5.2069	7.85084295622
YJ-her-002-P1	P-0003981	RETROSPECTIVE	MSK	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	T3N1	YES	NO	NO	LN, bone	UNKNOWN	GEJ	IMPACT300	3.260869565	NA	0.46	CIN	34.8	CR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 2+	3.5	POS	AMP	1.246712101	3.48547428591
YJ-her-004-M1a	YJ-her-004	RETROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Metastasis	IV	YES	NO	NO	BONE	NEGATIVE	Liver	IMPACT300	2.173913043	NA	0.22	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	2.416839742	2.32364952394
YJ-her-004-P	YJ-her-004	RETROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	YES	NO	NO	BONE	NEGATIVE	GEJ	IMPACT300	1.086956522	NA	0.47	CIN	6.6	PR	LTF	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	4.33778244	1.16182476197
YJ-her-005-P1	YJ-her-005	RETROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	NO	NO	LN, mediastinal, hilar, RP, subcutaneous, and adrenal	NEGATIVE	GEJ	IMPACT300	5.434782609	NA	0.24	CIN	5.6	POD	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	1.884011738	5.80912380986
YJ-her-005-P2	YJ-her-005	RETROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Esophageal Adenocarcinoma	ESCA	Primary	IV	NO	NO	NO	LN, mediastinal, hilar, RP, subcutaneous, and adrenal	NEGATIVE	GEJ	IMPACT300	6.52173913	NA	0.39	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	1.71501475	6.97094857183
YJ-her-006-P1	YJ-her-006	RETROSPECTIVE	OSH	PRE-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	LN	POSITIVE	GEJ	IMPACT300	7.608695652	NA	0.27	CIN	18.83	PR	DOD	OFF TREATMENT	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.435495252	8.1327733338
YJ-her-006-P2a	YJ-her-006	RETROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Primary	IV	NO	NO	YES	LN	POSITIVE	GEJ	IMPACT300	22.82608696	NA	0.25	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	2.263635404	24.3983200014
YJ-her-007-M2	P-0001158	RETROSPECTIVE	MSK	POST-TX	Esophagogastric Cancer	Stomach Adenocarcinoma	STAD	Metastasis	IV	YES	NO	YES	LN	NEGATIVE	Liver	IMPACT300	8.695652174	NA	0.36	CIN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	IHC 3+	NA	POS	AMP	3.93413903	9.29459809577
